Randomized Control Trial for Reduction of Body Weight, Body Fat Patterning, and Cardiometabolic Risk Factors in Overweight Worksite Employees in Delhi, India

Table 3

Mean values of anthropometric, clinical, and biochemical profiles at baseline.

Parameter	Intervention		Control		Intervention-control (Δ)	Statistical significance of intervention versus control at baseline
	n	Mean ± SD	n	Mean ± SD	Mean difference	values	values
Weight (kg)	156	81.67 ± 10.72	111	80.89 ± 12.24	0.77	0.536	0.592
BMI (kg/m^2)	156	28.21 ± 2.89	111	28.20 ± 3.59	0.02	0.039	0.969
Waist circumference (cm)	155	98.90 ± 8.58	111	98.89 ± 9.81	0.25	0.218	0.827
Hip circumference(cm)	155	103.70 ± 5.72	111	103.84 ± 7.83	−0.14	0.161	0.872
Waist-hip ratio	155	0.95 ± 0.06	111	0.96 ± 0.06	−0.01	0.798	0.425
Skinfolds (mm)
Biceps	155	8.69 ± 4.02	108	9.26 ± 3.86	−0.56	1.148	0.251
Triceps	155	16.64 ± 5.69	108	16.33 ± 5.66	0.32	0.443	0.658
Subscapular	155	22.83 ± 6.15	108	22.88 ± 6.08	−0.05	0.067	0.947
Suprailiac	155	18.11 ± 6.34	108	18.80 ± 6.76	−0.69	0.831	0.406
Sum of peripheral skinfolds	155	25.3 ± 10.13	108	25.6 ± 9.72	−0.25	0.201	0.841
Sum of central skinfolds	155	40.9 ± 12.27	108	41.7 ± 12.93	−0.80	0.504	0.614
Sum of 4 skinfolds (4SF)	155	66.28 ± 18.74	108	67.27 ± 18.84	−0.99	0.419	0.675
Systolic blood pressure (mmHg)	154	122.04 ± 13.04	100	124.67 ± 13.40	−2.63	1.547	0.122
Diastolic blood pressure (mmHg)	154	82.61 ± 8.95	100	83.87 ± 9.86	−1.25	1.025	0.305
Fasting blood glucose (mg/dl)	148	96.52 ± 12.29	102	98.03 ± 10.41	−1.51	−0.998	0.318
Total cholesterol (mg/dl)	148	187.74 ± 36.00	102	181.63 ± 36.72	6.10	1.302	0.193
High-density lipoprotein cholesterol (mg/dl)	148	40.90 ± 9.51	102	40.10 ± 8.32	0.80	0.700	0.484
Low-density lipoprotein cholesterol (mg/dl)	148	118.00 ± 26.98	102	117.57 ± 32.38	0.43	0.111	0.912
Serum triglycerides (mg/dl)	148	145.74 ± 80.4	102	137.31 ± 62.48	8.43	0.931	0.352